Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,447.60 +60.05 0.39%
S&P 500 1,675.98 +6.82 0.41%
Nasdaq 3,509.55 +7.42 0.21%
Ticker Volume Price Price Delta
STOXX 50 2,826.46 +4.81 0.17%
FTSE 100 6,840.62 +36.75 0.54%
DAX 8,507.54 +35.34 0.42%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: Copenhagen
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

H Lundbeck A/S

+ Add to Watchlist

LUN:DC

115.3000 DKK 0.7000 0.60%

As of 10:26:32 ET on 05/22/2013.

Company Profile for H Lundbeck A/S (LUN)

H. Lundbeck A/S is an international pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders. The Company focuses on mood disorders, dementia, anxiety, and sleep disorders. Lundbeck does research both in-house and in cooperation with research centers. The Company markets its products worldwide.

Contact Information

H Lundbeck A/S

Ottiliavej 9
Valby
Copenhagen, 2500
Denmark
Phone: 45-36-30-13-11
Fax: 45-36-30-19-40

Key Executives for H Lundbeck A/S (LUN)

Thorleif KrarupDeputy ChairmanChristian DyvigVice Chairman
Ulf WiinbergPresident/CEOAnders GotzscheExec VP/CFO
Anders Gersel PedersenExec VP:Research & DevJorn MayntzhusenSenior Mgr:Supply Optimisation

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil